Chapter II of IV · Feeding Your Dog

Lagotto Romagnolo feeding schedules and portions by life stage, feeding as enrichment for a working mind, and which joint supplements the evidence supports.

This chapter is part of our evidence-based feeding guide for the Lagotto Romagnolo. The two-minute summary, the research library with every study cited, and the questions families ask live on the guide overview.

Feeding Schedules and Portions

Measured meals, not free-feeding. This is non-negotiable. Dogs fed from a bowl left full all day eat substantially more than dogs fed measured portions on a schedule, and according to the Association for Pet Obesity Prevention’s 2024 survey, approximately 59% of dogs in the United States are classified as overweight or obese, 37% overweight, 22% obese. Portion control is one of the simplest and most consequential interventions you can make.

Measured meals also let you notice appetite changes, one of the earliest signs of illness in any dog. A dog that skips a measured meal tells you something. A dog that grazes from a bowl all day tells you nothing until the problem is advanced.

8–12 Weeks

3–4 meals daily. Follow the feeding guide on the bag for the puppy’s age and weight. Adjust based on body condition, not the calendar.

3–6 Months

3 meals daily. Portions increase as the puppy grows. Energy needs peak during this period, roughly twice that of an adult dog.

6–12 Months

2 meals daily. Energy needs are declining to about 1.2× adult levels. Monitor body condition carefully. This is where overfeeding becomes visible.

12+ Months

2 meals daily. Transition to adult food over 2 weeks at 12–14 months for medium breeds. Morning and evening. For life.

ⓘ
2022 Research, Meal Frequency

A high-profile 2022 analysis from the Dog Aging Project (Bray et al., GeroScience) examined 24,238 companion dogs and found that adult dogs fed once daily showed lower odds of gastrointestinal, dental, orthopedic, kidney, and liver disorders, and better cognitive scores, than dogs fed more frequently. This is interesting, but needs two important caveats. First, the study is cross-sectional and correlational. The authors explicitly do not recommend changing your dog’s feeding schedule based on it. Second, the finding applies only to adult dogs. Puppies need multiple meals daily through at least 12 months. For adult dogs, twice daily remains a reasonable default, and the research does not suggest you’re doing harm with that schedule.

Foundation, 8 to 12 weeks

The first month home

The most important window for establishing the relationship with food, the crate routine, and body condition habits that will persist for life. Feed whatever the breeder sent home with you for the first two weeks minimum. Transition slowly if you change brands.

Meals3 to 4 small meals daily, measured.
FoodPuppy formula or all-life-stages with AAFCO Growth statement.
Body conditionRibs easily felt. Slight tummy tuck from side.
Do not add: calcium, bone meal, raw bones, cottage cheese in large quantities, or any mineral supplement. The food is already balanced.

Rapid Growth, 3 to 6 months

Peak energy demand

Energy needs are at their lifetime maximum, roughly twice the adult requirement per unit of body weight. Portions will seem large. Growth is fast, joints are forming, and overfeeding now has permanent consequences. Trust body condition over feeding charts.

Meals3 meals daily, measured.
Growth platesStill open. Protect from stair impact and repetitive high-impact loading.
MonitorWeekly weight checks. Adjust portions up or down by body condition, not by chart.
Highest risk period for overfeeding. Every study of diet-related developmental orthopedic disease flags the 3-to-6-month window as the most vulnerable.

Adolescence, 6 to 12 months

Energy tapers, habits solidify

Energy needs drop to roughly 1.2× adult levels. Body condition at 7 months predicts adult weight (Leclerc et al. 2017). If you let your dog get pudgy now, you will be managing that dog’s weight for life. Transition to 2 meals daily. Maintain puppy food through 12 months unless directed otherwise.

MealsDrop to 2 daily, measured.
FoodStill puppy formula through 12 months for medium breeds.
ExerciseGrowth plates close at roughly 12–14 months for medium breeds. Continue caution with high-impact loading. Continue caution with high-impact loading.

Adult Maintenance, 1 to 7 years

The long plateau

Transition to adult food over two weeks at 12 to 14 months. Twice daily, measured, maintaining BCS 4 to 5. This is the longest life stage and the easiest to neglect. Adult dogs drift heavier over years, and the drift is rarely noticed by the people who see the dog every day.

Weigh every 3 monthsObjective numbers catch drift that eyes miss.
TreatsNo more than 10% of daily calories. Count them.
SupplementsFor a healthy lean dog, none required. See Section VI.

Senior, 8 years and up

Where the supplement evidence actually applies

Metabolism slows. Muscle mass needs protection. Senior dogs need adequate protein, not reduced protein. This is where joint supplements move from “optional” to “potentially useful” for dogs with diagnosed osteoarthritis or early stiffness. The evidence for marine omega-3 and cold-processed green-lipped mussel is real at this stage.

Adequate proteinDo not reduce protein unless directed for kidney disease.
Omega-3~100 mg EPA+DHA per kg body weight daily has the best evidence.
Veterinary careFor diagnosed OA, NSAIDs and Librela (bedinvetmab; EU 2020, US 2023) are far better supported than supplements; discuss benefits and side effects with your vet.

Seven-month body condition predicts adult weight. Leclerc, Serisier and colleagues’ longitudinal study of female Beagles, published in BMC Veterinary Research, identified body condition score at seven months as a direct predictor of adult obesity. The larger 2024 Banfield retrospective of 4.9 million dogs confirmed the effect at scale. What you set in the first year is what you will manage for the rest of your dog’s life.

Feeding as a Mind Game

Meals are the biggest mental event in most dogs’ days. If you pour food into a bowl and walk away, you are wasting a resource that could be doing real enrichment work, and for working breeds like Lagotti, but also for Border Collies, Retrievers, Poodles, and any other dog bred to think hard. This matters more than most owners realize. A dog that has to work for its food uses its brain. A dog that uses its brain is calmer, more satisfied, and better behaved.

We tell families to feed at least one meal a day through something that requires effort. The specific object is less important than the principle: slow down, work for it, engage.

Snuffle mats
Kibble hidden in fabric fronds that the dog has to nose through. Satisfies the truffle-hunting instinct in the Lagotto specifically, but works for any scent-oriented dog.
Frozen Kongs
Kibble mixed with a small amount of wet food, water, or plain yoghurt, frozen. Twenty minutes of focused work. The standard for settling a puppy in a crate.
Puzzle toys
Outward Hound, Nina Ottosson, Trixie make good ones. Start easy. Let the dog succeed. Escalate difficulty over weeks.
Scatter feeding
Throw the kibble into the grass in the backyard and let the dog hunt it down. Free, takes thirty seconds to set up, works better than most purchased toys.

Meals become the day’s richest enrichment, not an afterthought. Dogs that work for their food are calmer, more satisfied, and less prone to the destructive behaviors that come from understimulated intelligence. If you have a working breed, this is not optional; it is the difference between a settled dog and a frustrated one.

Joint Supplements: What the Evidence Actually Supports

The joint supplement market is enormous, largely unregulated, and, this matters, mostly built on marketing claims that do not match what the peer-reviewed veterinary literature actually shows. Before we tell you what works, we want you to understand the kinds of claims you will encounter when you start shopping. Most of them will not survive scrutiny.

Claims to Watch For, and Why to Be Skeptical
Clinically proven to work in 6 weeks.
Usually refers to a single manufacturer-funded study held as “data on file” and not published in a peer-reviewed journal. Always ask: published where? If the answer is “our website,” that is not peer-reviewed evidence.
83% of dogs showed improvement.
Usually traces to one small early study, presented as if consistent across the literature. Subsequent, more rigorous trials almost always show smaller effects or none at all.
Supports joint health in young active dogs.
The entire canine joint supplement literature is a treatment literature. Studies are run on dogs with diagnosed osteoarthritis. There is essentially no peer-reviewed evidence that supplementing a healthy young dog prevents problems later.
Outperforms NSAIDs with no side effects.
A few specific supplements (PCSO-524, UC-II) have shown effects similar to NSAIDs in short trials on dogs with diagnosed OA. None has been shown to outperform them. “No side effects” mostly means “no published safety trials long enough to find any.”
Veterinarian recommended.
Every joint supplement on the market can make this claim because some veterinarian, somewhere, has recommended it. It tells you nothing about peer-reviewed evidence. Ask which trial supports it.

With that context, here is what the evidence actually shows, ranked by strength of peer-reviewed support.

Tier 1, Strong Evidence

Weight management

Not a supplement, but the largest effect size of anything ever studied for canine joint health. The Purina study found 57–72% fewer hip dysplasia cases at age two, and osteoarthritis delayed by 1.5 years, just from keeping dogs lean. Burkholder & Hulse (2000) showed that weight loss alone improves ground reaction forces in dogs with hip OA. No supplement comes close.

Kealy et al. 1992, 2002; Lawler et al. 2008; Burkholder & Hulse 2000

Marine omega-3 (EPA and DHA)

The best-studied joint supplement in dogs, with multiple large, blinded, multi-site trials. Roush 2010 (127 dogs, 18 clinics) showed improved weight bearing over 6 months. Mehler 2016 dosed at 69 mg EPA+DHA/kg/day showed ~50% improvement in crepitus, pain, and joint effusion at 42 days. Fritsch 2010 demonstrated dose-dependent response across 177 dogs. Therapeutic range is 50–220 mg EPA+DHA per kg body weight per day; target roughly 100 mg/kg/day for dogs with active OA. Benefits reach well beyond joints, skin, coat, cognition, cardiovascular, kidney.

Roush et al. 2010; Mehler et al. 2016; Fritsch et al. 2010; Bauer 2011

Fish Oil Dose Calculator
Calculate therapeutic EPA+DHA range based on your dog’s weight. Target roughly 100 mg per kg body weight per day for dogs with diagnosed osteoarthritis. Confirm any therapeutic dose with your veterinarian.
Therapeutic Range, EPA+DHA per day

Tier 2, Good Evidence, With Caveats

Green-lipped mussel (cold-processed lipid extract)

Green-lipped mussel (Perna canaliculus) is a real supplement with real effects, but only in cold-processed lipid extract form. Heat processing destroys the bioactivity, so the powdered or heat-dried versions in most commercial joint chews are much weaker than marketing implies. The strongest peer-reviewed evidence is for PCSO-524 (marketed as Antinol). Kampa et al. 2023 (Frontiers in Veterinary Science) ran a prospective, block-randomized, double-blinded, placebo-controlled trial of 75 dogs with hip osteoarthritis. PCSO-524 produced improvements in peak vertical force (an objective gait measurement) equivalent to carprofen by week 4, and significantly better than glucosamine-chondroitin or placebo. A 2024 follow-up confirmed similar findings for a GLM-krill combination (EAB-277).

Kampa et al. 2023, 2024; Hielm-Björkman 2009; Bierer & Bui 2002; Pye et al. 2024

Undenatured Type II Collagen (UC-II)

More evidence than most skeptics give it credit for, less than its marketing suggests. Gupta et al. 2012 (J Animal Physiology and Animal Nutrition) showed UC-II outperforming glucosamine-chondroitin on force-plate measurements in arthritic dogs over 150 days. Stabile et al. 2019 found UC-II producing 30-day improvements similar in magnitude to the NSAID robenacoxib. Two caveats: most UC-II research is funded by Lonza/InterHealth (the manufacturer), and the widely-cited effect sizes come from studies that have not yet been independently replicated at the same magnitude. Belongs in Tier 2, not Tier 1.

Gupta et al. 2012; Stabile et al. 2019, 2022

Tier 3, Weak or Mixed Evidence

Glucosamine and chondroitin sulfate

The most widely sold joint supplement in the world, and the one with the weakest evidence base. Multiple high-quality blinded trials consistently show it failing to beat placebo on objective measures. Moreau 2003, McCarthy 2007, Vandeweerd 2012 systematic review (rating the global strength of evidence as “low”), and most recently Kampa 2023 (statistically indistinguishable from placebo while GLM matched carprofen). Why is it still so widely sold? It is cheap, safe, palatable, and entrenched by marketing momentum. Owner-reported improvement is real but traces to caregiver placebo effect. The owners expect to see improvement and they see it, while objective gait measurements do not change.

Moreau et al. 2003; McCarthy et al. 2007; Vandeweerd et al. 2012; Bhathal et al. 2017; Kampa et al. 2023

Turmeric, boswellia, MSM, hyaluronic acid (oral)

All have some mechanistic rationale and a few small dog trials. None has the replication or sample size to justify a strong recommendation. Usually included in multi-ingredient joint chews as kitchen-sink additions. Reasonable as adjuncts if your vet specifically suggests them for a dog with diagnosed OA; not worth buying on their own.

Limited, mixed, mostly small-sample

The Prevention Question

We want to be direct about something that the supplement industry obscures. The entire canine joint supplement literature is a treatment literature. Every trial cited above was run on dogs with diagnosed, radiographically confirmed osteoarthritis, usually middle-aged to senior dogs with clinical lameness. There is essentially no peer-reviewed evidence that supplementing a structurally sound, healthy two-year-old dog prevents joint problems later in life. None of the omega-3, green-lipped mussel, UC-II, or glucosamine studies were run on healthy young dogs as a prevention protocol.

This means when you see a supplement marketed for “preventive joint support” in young dogs, that is an extrapolation from treatment data, not a finding. It is the most unsupported claim in the joint supplement market, and also one of the most common. The best-evidenced prevention for young dogs is exactly what the Purina study showed: stay lean, protect growth plates, feed a complete diet. Everything else is optional.

Where Should I Start?
An age-calibrated recommendation.
How old is your dog?

Start over

Frequently Asked Questions

›How much fish oil should I give a dog with arthritis?

The therapeutic range in the trials is about 50–220 mg of combined EPA and DHA per kg of body weight per day; roughly 100 mg/kg/day is a sensible target for a dog with active osteoarthritis. Check the EPA and DHA content on the label rather than the total fish oil, and discuss the dose with your vet.

›Does glucosamine work for dogs?

The evidence is weak. Blinded trials (Moreau 2003, McCarthy 2007) and a systematic review (Vandeweerd 2012) found it failing to beat placebo on objective measures, and Kampa 2023 found it statistically indistinguishable from placebo while green-lipped mussel matched carprofen. It is cheap and safe, which is why it is still widely sold.

›When do a Lagotto’s growth plates close?

Most growth plates in a medium breed close at roughly 12–14 months. Keep a puppy lean, avoid repetitive high-impact exercise through the first year, and carry a young puppy on stairs; our own rule is no stairs or jumping down from above belly height before four months.

Questions About Feeding Your Dog?

Nutrition decisions compound over years. If you have a specific question about your own dog, what to feed, when to switch, what supplement to try, how to read a label. we’re happy to answer one. Not a consultation. Not a service. Just a question, answered from eleven years of experience and the peer-reviewed literature this article draws on.

If you’re considering a Lagotto and want to know what we do at Northwest Lagotto, the waitlist and breed pages are the right places to start.

Ask a Question → Begin the Conversation →
MN
Mark Nelson
Breeder · Northwest Lagotto LLC · Lynden, Washington

Eleven years with the Lagotto Romagnolo breed. Northwest Lagotto is a selective, health-tested Lagotto Romagnolo breeding program in Lynden, Washington, operating on a waitlist basis with 1–2 litters per year from Italian championship lines (Il Granaio Dei Malatesta, Gillenias). This essay draws on that experience and on the peer-reviewed veterinary literature cited throughout. When the literature disagrees with common practice, the literature wins.

Nutrition Quick Reference

Feeding amounts by weight and age, how to transition foods safely, supplement guidance, and what to leave out, distilled to a single page.

Download the PDF

Sources for This Chapter

  1. Kealy RD, Olsson SE, Monti KL, et al. Effects of limited food consumption on the incidence of hip dysplasia in growing dogs. JAVMA 1992;201(6):857–863. PMID: 1399793.
  2. Kealy RD, Lawler DF, Ballam JM, et al. Effects of diet restriction on life span and age-related changes in dogs. JAVMA 2002;220(9):1315–1320. PMID: 11991408.
  3. Lawler DF, Larson BT, Ballam JM, et al. Diet restriction and ageing in the dog: major observations over two decades. Br J Nutr 2008;99(4):793–805. PMID: 18062831.
  4. Leclerc L, Thorin C, Flanagan J, Biourge V, Serisier S, Nguyen P. Higher neonatal growth rate and body condition score at 7 months are predictive factors of obesity in adult female Beagle dogs. BMC Vet Res 2017;13:104. PMID: 28407742.
  5. Bray EE, Zheng Z, Tolbert MK, et al. Once-daily feeding is associated with better health in companion dogs. GeroScience 2022;44(3):1779–1790. PMID: 35484470.
  6. Association for Pet Obesity Prevention. 2024 State of U.S. Pet Obesity Report.
  7. Burkholder WJ, Hulse DA. 2000 [weight loss and ground reaction forces in dogs with hip osteoarthritis].
  8. Roush JK, Dodd CE, Fritsch DA, et al. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. JAVMA 2010;236(1):59–66. PMID: 20043800.
  9. Mehler SJ, May LR, King C, et al. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins Leukot Essent Fatty Acids 2016;109:1–7. PMID: 27269707.
  10. Fritsch DA, Allen TA, Dodd CE, et al. A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. JAVMA 2010;236(5):535–539. PMID: 20187817.
  11. Bauer JE. Therapeutic use of fish oils in companion animals. JAVMA 2011;239(11):1441–1451. PMID: 22087720.
  12. Kampa N, Kaenkangploo D, Jitpean S, et al. Study of the effectiveness of glucosamine and chondroitin sulfate, marine based fatty acid compounds (PCSO-524 and EAB-277), and carprofen for the treatment of dogs with hip osteoarthritis. Front Vet Sci 2023;10:1033188. PMID: 36816197.
  13. Kampa N, Kaenkangploo D, Jitpean S, et al. Evaluation of the comparative efficacy of green lipped mussel plus krill oil extracts (EAB-277), Biota orientalis extracts or NSAIDs for the treatment of dogs with osteoarthritis associated pain. Front Vet Sci 2024;11:1464549. PMID: 39450405.
  14. Hielm-Björkman A, Tulamo RM, Salonen H, Raekallio M. Evaluating complementary therapies for canine osteoarthritis part I: green-lipped mussel (Perna canaliculus). Evid Based Complement Alternat Med 2009;6(3):365–373. PMID: 18955269.
  15. Bierer TL, Bui LM. Improvement of arthritic signs in dogs fed green-lipped mussel (Perna canaliculus). J Nutr 2002;132(6 Suppl 2):1634S–1636S. PMID: 12042477.
  16. Pye C, Clark N, Bruniges N, Peffers M, Comerford E. Current evidence for non-pharmaceutical, non-surgical treatments of canine osteoarthritis. J Small Anim Pract 2024;65(1):3–23. PMID: 37776028.
  17. Gupta RC, Canerdy TD, Lindley J, et al. Comparative therapeutic efficacy and safety of type-II collagen (UC-II), glucosamine and chondroitin in arthritic dogs. J Anim Physiol Anim Nutr 2012;96(5):770–777. PMID: 21623931.
  18. Stabile M, Samarelli R, Trerotoli P, et al. Evaluation of the effects of undenatured type II collagen (UC-II) as compared to robenacoxib on the mobility impairment induced by osteoarthritis in dogs. Vet Sci 2019;6(3):72. PMID: 31487772.
  19. Stabile M, Lacitignola L, Samarelli R, et al. Evaluation of clinical efficacy of undenatured type II collagen supplementation compared to cimicoxib and their association in dogs affected by natural occurring osteoarthritis. Res Vet Sci 2022;151:27–35. PMID: 35853328.
  20. Moreau M, Dupuis J, Bonneau NH, Desnoyers M. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet Rec 2003;152(11):323–329. PMID: 12665145.
  21. McCarthy G, O’Donovan J, Jones B, et al. Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. Vet J 2007;174(1):54–61. PMID: 16647870.
  22. Vandeweerd JM, Coisnon C, Clegg P, et al. Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis. J Vet Intern Med 2012;26(3):448–456. PMID: 22404506.
  23. Bhathal A, Spryszak M, Louizos C, Frankel G. Glucosamine and chondroitin use in canines for osteoarthritis: a review. Open Vet J 2017;7(1):36–49. PMID: 28331832.